Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

LU-51198 prevents complement-mediated myocardial injury

Sep. 1, 1997

What's new in Cardiology? Highlights from the 19th Congress of the European Society of Cardiology

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

Innothera discloses more agents for venous function deficiency

Aug. 29, 1997

SYST-EUR trial results presented

Aug. 29, 1997

DIAMOND CHF study results reported

Aug. 29, 1997

Val-HeFT will evaluate valsartan in CHF

Aug. 28, 1997

Gensia's injectable diltiazem receives ANDA approval

Aug. 28, 1997

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Aug. 28, 1997

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...